320.86
price down icon0.11%   -0.34
 
loading

Penumbra Inc 주식(PEN)의 최신 뉴스

pulisher
Oct 15, 2026

MarketBeat cites USD 367.07 average target for Penumbra stock - ad-hoc-news.de

Oct 15, 2026
pulisher
Oct 08, 2026

Could STORM-PE Data Change Penumbra (NASDAQ:PEN) Story? - Kalkine Media

Oct 08, 2026
pulisher
Oct 08, 2026

Penumbra (PEN) Clinical Data Puts Its Valuation Back In Focus - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

Penumbra presented STORM-PE data while Penumbra stock trades at EUR 281.30 - AD HOC NEWS

Oct 08, 2026
pulisher
Oct 08, 2026

Penumbra (BSP:P2NB34) Total Tax Payable : R$ Mil (As of Jun. 2026) - GuruFocus

Oct 08, 2026
pulisher
Oct 07, 2026

Operating cash flow per share of Penumbra, Inc. – HAN:0P8 - TradingView

Oct 07, 2026
pulisher
Oct 06, 2026

New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism - BioSpace

Oct 06, 2026
pulisher
Oct 06, 2026

Penumbra stock gets fresh STORM-PE data catalyst - AD HOC NEWS

Oct 06, 2026
pulisher
Oct 06, 2026

Behavioral Patterns of PEN and Institutional Flows - Stock Traders Daily

Oct 06, 2026
pulisher
Oct 06, 2026

Penumbra (PEN) Highlights Wearable Device Data Linking Activity to Recovery in Pulmonary Embolism Trial - GuruFocus

Oct 06, 2026
pulisher
Oct 06, 2026

New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism - PR Newswire

Oct 06, 2026
pulisher
Oct 06, 2026

In a lung-clot study, fitness-watch steps lined up with clinic walking tests - Stock Titan

Oct 06, 2026
pulisher
Oct 06, 2026

New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism - Nasdaq

Oct 06, 2026
pulisher
Oct 05, 2026

Penumbra stock reports 14.9 percent revenue growth as EPS misses - AD HOC NEWS

Oct 05, 2026
pulisher
Oct 02, 2026

Boston Scientific keeps Penumbra deal on track as Penumbra stock costs EUR 284.00 - AD HOC NEWS

Oct 02, 2026
pulisher
Oct 01, 2026

Penumbra, Inc. (PEN) Stock forecasts - Yahoo Finance UK

Oct 01, 2026
pulisher
Oct 01, 2026

Revenue per share of Penumbra, Inc. – HAN:0P8 - TradingView

Oct 01, 2026
pulisher
Oct 01, 2026

Penumbra stock breaks below 50-day average - AD HOC NEWS

Oct 01, 2026
pulisher
Oct 01, 2026

IART vs. PEN: Which Stock Is the Better Value Option? - Zacks Investment Research

Oct 01, 2026
pulisher
Sep 30, 2026

Current ratio of Penumbra, Inc. – HAN:0P8 - TradingView

Sep 30, 2026
pulisher
Sep 30, 2026

Average basic shares outstanding of Penumbra, Inc. – HAN:0P8 - TradingView

Sep 30, 2026
pulisher
Sep 30, 2026

Penumbra, Inc. (PEN) Stock Forecasts - Yahoo Finance

Sep 30, 2026
pulisher
Sep 29, 2026

IART or PEN: Which Is the Better Value Stock Right Now? - Zacks Investment Research

Sep 29, 2026
pulisher
Sep 26, 2026

The Technical Signals Behind (PEN) That Institutions Follow - news.stocktradersdaily.com

Sep 26, 2026
pulisher
Sep 24, 2026

Anaconda Biomed raises $56m for catheter portfolio’s advance - Yahoo Finance

Sep 24, 2026
pulisher
Sep 23, 2026

Penumbra, Inc. (PEN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 23, 2026

Penumbra, Inc. (PEN) Stock Forecasts - Yahoo Finance

Sep 23, 2026
pulisher
Sep 21, 2026

ETFs Investing in Penumbra, Inc. Stocks - TradingView

Sep 21, 2026
pulisher
Sep 20, 2026

Penumbra Inc. stock trades near 317 dollars as investors weigh growth and valuation - AD HOC NEWS

Sep 20, 2026
pulisher
Sep 19, 2026

Penumbra Inc. stock holds near 315 dollars as growth expectations stay high - AD HOC NEWS

Sep 19, 2026
pulisher
Sep 18, 2026

Penumbra Stock Price Forecast. Should You Buy PEN? - StockInvest.us

Sep 18, 2026
pulisher
Sep 16, 2026

Reasons to Retain Penumbra Stock in Your Portfolio for Now - Yahoo Finance

Sep 16, 2026
pulisher
Sep 16, 2026

Reasons to Retain Penumbra Stock in Your Portfolio for Now - Eastern Progress

Sep 16, 2026
pulisher
Sep 14, 2026

Penumbra, Inc. (PEN) Stock Analysis: Navigating Growth With A 13.88% Potential Upside - DirectorsTalk Interviews

Sep 14, 2026
pulisher
Sep 07, 2026

Price to earnings forward of Penumbra, Inc. – NYSE:PEN - TradingView

Sep 07, 2026
pulisher
Sep 07, 2026

Penumbra, Inc. (PEN): Growth Potential Amidst Analyst Consensus And Market Dynamics - directorstalkinterviews.com

Sep 07, 2026
pulisher
Sep 05, 2026

Discipline and Rules-Based Execution in PEN Response - Stock Traders Daily

Sep 05, 2026
pulisher
Sep 05, 2026

BSP:P2NB34 Enterprise Value: R$-100 Mil | Fairly Valued - GuruFocus

Sep 05, 2026
pulisher
Sep 05, 2026

BSP:P2NB34 Shareholder Yield %: 0.05% | Fairly Valued - GuruFocus

Sep 05, 2026
pulisher
Sep 05, 2026

BSP:P2NB34 Revenue: R$7,963 Mil | Fairly Valued - GuruFocus

Sep 05, 2026
pulisher
Sep 04, 2026

BSP:P2NB34 GF Value: R$57.41 | Fairly Valued - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

BSP:P2NB34 ROCE %: 10.74% | Fairly Valued - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

Penumbra (BSP:P2NB34) Loans Receivable : R$0 Mil (As of Jun. 2026) - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

Penumbra Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

BSP:P2NB34 3-Year EPS without NRI Growth Rate: 188.40% — 5 - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

Penumbra (BSP:P2NB34) Land And Improvements : R$0 Mil (As of Jun. 2026) - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

Q3 2025 Penumbra Inc Earnings Call Transcript - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

BSP:P2NB34 Other Current Assets: R$268 Mil | Fairly Valued - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

Penumbra (BSP:P2NB34) Total Long-Term Assets : R$3,231 Mil (As of Jun. 2026) - GuruFocus

Sep 04, 2026
pulisher
Sep 04, 2026

BSP:P2NB34 Net Income: R$853 Mil | Fairly Valued - GuruFocus

Sep 04, 2026
SNN SNN
$29.06
price down icon 0.10%
$76.71
price down icon 2.70%
$141.10
price up icon 1.68%
$364.15
price down icon 0.25%
$164.84
price down icon 0.46%
BIO BIO
$353.70
price down icon 3.05%
자본화:     |  볼륨(24시간):